GALR2 activation subsequently induces tumor cells to secrete pro-inflammatory mediators and neuropeptides that promote invasion and PNI through NFATC2 (nuclear factor of activated T cells 2)-mediated cyclooxygenase-2 expression. The gene discussed is NFATC2; the disease is neoplasm.